9 oct 2018
CPhI Worldwide 2018
Wanbang Biopharmaceuticals

Wanbang Biopharmaceuticals

Exhibitor at CPhI Worldwide 2018 stand 5H10, API

About us

Wanbang Biopharmaceuticals Co Ltd focuses on developing, manufacturing, and selling pharmaceuticals for patients of diabetes and related cardiovascular diseases. Its products include animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium. The company's products also comprise aloe compound capsules for clearing liver-heat, relaxing bowels, and calming heart for tranquillization; and products in the fields of chemicals, pharmaceuticals, and biotech, such as Human Interferon, Human Erythropoietin, Streptokinase, and Pemetrexed disodium. It sells products through a network of distributors and sales representatives in China and internationally. The company was founded in 1981 and is based in Xuzhou, China. Wanbang Biopharmaceuticals Co Ltd operates as a subsidiary of Shanghai FOSUN Pharmaceutical (Group) Co Ltd.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Capsules More

Products featured at CPhI Worldwide 2018

Categories affiliated with Wanbang Biopharmaceuticals

Wanbang Biopharmaceuticals

Event information

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 5H10